Pharmaceutical industry news

SK Biopharm's In-Licensed Epilepsy Drug OPCALIM Hits Partial FDA Clinical Hold

HHS appoints permanent FDA CBER, CDER heads

Spain pushes for ‘access toolbox’ in EU biotech rules

Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group

US appeals court skeptical of bid to curtail abortion pill access

Join the Danish Medicines Agency’s ATMP Open House

Web-émission – Vagues de chaleur : notre santé à l’épreuve

What to expect from UniQure’s upcoming Huntington’s gene therapy readout

Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon

Squarepoint Ops LLC Sells 106,171 Shares of Ultragenyx Pharmaceutical Inc. $RARE

Teva Pharmaceutical Industries Prices $4.9 Billion Senior Notes Offering and Announces Conditional Redemptions

Aiforia honors three AI pioneers in digital pathology at the 38th European Congress of Pathology

Clínic Barcelona publishes its 2025 Annual Report

Power Optimization Solution Ends Costly Grid-Related Shutdowns at Major Pharmaceutical Manufacturing Plant

Active Pharmaceutical Ingredients Market Demand Insights

One assessment, 27 countries: how EU joint reviews work

When the ER Is Not an Option: Milestone’s CMO on Bringing AFib Rate Control Home

Takeda Pharmaceutical Co Ltd - Takeda Announces Planned Retirement Of President Of Research & Development Andy Plump Effective June 2027

Takeda Pharmaceutical : Announces Planned Retirement of President of Research & Development Andy Plump

Systech launches TraceIQ

How UD's STAR Campus is helping companies foster innovation in biotech

UKRI modernises grant assessment for the age of AI

Biotech Growth Trust Stands Out In A Stronger Biotechnology Sector

ME Therapeutics Stock Faces Downside Pressure as Biotech Risk and Preclinical Uncertainty Weigh on Sentiment

BioCorRx Inc. Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory Board

Yourgene Insight DPYD assay gets IVDR accreditation

FDA places partial clinical hold on SK Biopharm's epilepsy drug candidate opacalim

#SCATTIDIUNTEMPO 1906– 2026: ricorrono i 120 anni della Clinica Mangiagalli, la storica “culla d’Italia” tra memoria, eccellenza e futuro

エンスプリングに関するロシュ社の発表について（MOG抗体関連疾患に対するFDAによる申請受理および優先審査指定）

Roche Announces U.S. FDA Grants Priority Review for Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Samsung Biologics Signs ₩350.8 Billion Long-Term CMO Deal with European Pharmaceutical Company

Biotech Fluidics launch DEGASi NG platform

Dong-A Socio Holdings to rename itself Dong-A Pharmaceutical after OTC merger

Biotech Fluidics upgrades its Degasi inline degasser range

Why evidence matters: Seema Meloni on making data meaningful

Mpox clade Ib and clade IIb outbreak: epidemiological overview

The latest information on mpox clade Ib and clade IIb cases in the UK and mpox vaccine administratio...

Meningococcal disease: laboratory-confirmed cases in England 2025 to 2026

Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal...

Antimicrobial resistance awareness: toolkit for healthcare providers

Resources for World Antimicrobial Resistance Awareness Week (WAAW) and European Antibiotic Awareness...

Newly discovered DNA protection mechanism linked to human brain development

Venture investor: Danish biotech innovation has caught up with Sweden

Pharmaceutical Packaging Market

Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

EUR Sustainability Award for the Integrated Implementation of EU Sustainability Legislation

Gov. Healey eyes changes to life sciences programs as early-stage biotechs struggle

Parkinson: Fortschritt nutzen – besser behandeln

Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer

Farmak Expands Its Panjest Dietary Supplement Range with New Panjest® Lactase

Weekly all-cause mortality surveillance: week ending 6 September 2026

How the actual number of deaths in England compare with expected numbers for each week.

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections: quarterly data up to April to June 2027

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections: quarterly data up to January to March 2027

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections: quarterly data up to October to December 2026

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections: quarterly data up to July to September 2026

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

HHS Names Permanent Leaders of FDA Drug and Vaccine Centers, Setting the Direction for Future Reviews

Scientists reveal what damages the DNA in most prostate cancers

Medizinischer Fortschritt benötigt klinische Forschung

UZL Newsletter Nr. 44 vom August 2026

Author of “Principles of Resilience,” a Book Marking Farmak’s 100-Year History, Honoured with the Kyiv Book of the Year 2026 Award

GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Japan

A new treatment improves the main symptoms of narcolepsy

CPAP clinic helps children overcome barriers to sleep apnea treatment